Results 121 to 130 of about 197,714 (301)
A dual‐function cell‐free therapeutic based on DC2.4 cell‐derived exosomes engineered to display BCMA. (Left) Soluble Ligand Sequestration (Decoy Function): DB Exo act as molecular decoys that predominantly sequester soluble APRIL with partial BAFF attenuation, effectively disrupting the NF‐κB survival signaling axis and suppressing myeloma cell ...
Yuqing Zeng +5 more
wiley +1 more source
LP-126 The infectious complication in multitarget therapy of class V lupus nephritis: a case report
Anastasiia Shumilova +3 more
doaj +1 more source
Exosomal miR‐146a‐5p is identified as a pivotal regulator in steroid‐induced osteonecrosis. Its reduction activates NF‐κB signaling, compromises mitophagy, and disrupts mitochondrial bioenergetics, resulting in autophagic disequilibrium. Engineered exosomes delivering miR‐146a‐5p reinstate mitochondrial function, augment oxidative phosphorylation and ...
Zehui Lv +13 more
wiley +1 more source
LP-048 Characteristics and clinical outcome of incomplete systemic lupus erythematosus
Anastasiia Shumilova +6 more
doaj +1 more source
OBJECTIVE: To determine the serum levels of interferon alpha in childhood-onset systemic lupus erythematosus patients, their first-degree relatives and healthy controls and to evaluate the associations between serum interferon alpha and disease activity,
Mariana Postal +5 more
doaj
Recurrent podocytopathy in a patient with systemic lupus erythematosus
Podocytopathy in systemic lupus erythematosus is characterised by diffuse foot process effacement without significant peripheral capillary wall immune deposits as seen on electron microscopy.
Shereen Paramalingam +3 more
doaj +1 more source
Decoupling biological signals from unwanted variation in multi‑condition single‑cell RNA sequencing data remains challenging. CAPER disentangles condition‑associated biological effects from sample heterogeneity through matrix factorization, producing interpretable latent factors and a batch‑corrected expression matrix.
Ye Li +6 more
wiley +1 more source
New Advances in the Treatment of Systemic Lupus Erythematosus [PDF]
The thesis titled "New Advances in the Treatment of Systemic Lupus Erythematosus" explores recent developments and breakthroughs in the medical field pertaining to the treatment of Systemic Lupus Erythematosus (SLE).
Hassanpour, Sedigheh
core
OBJECTIVE: To determine the serum levels of interferon alpha in childhood-onset systemic lupus erythematosus patients, their first-degree relatives and healthy controls and to evaluate the associations between serum interferon alpha and disease activity,
Mariana Postal +5 more
doaj

